prostate cancer
Conditions
Interventions
None listed
Sponsors
Department of Radiation Oncology, Shonan Kamakura General Hospital, Kamakura, Japan; Sachika Shiraishi
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) Patients over 20 years of age with localized prostate cancer (cT1-T3aN0M0) 2) Patients requesting spacer insertion and gold marker insertion. 3)Intermediate/high-risk group: patients who have been on hormone therapy for more than 6 months 4) Patients who can visit the hospital during PT. 5) Patients who have been informed about this study and have given written consent.
Exclusion criteria
Exclusion criteria: 1) Patients with cT3b or higher 2) Patients with a history of pelvic surgery 3) Patients with previous pelvic radiotherapy 4) Patients with poor control of urination and defecation who are receiving medications. 5) Patients with active malignancy other than prostate cancer 6) Other patients deemed by the investigator to be incompatible with this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Acute-subacute and late urinary toxicity (within 2 year) | — |
Secondary
| Measure | Time frame |
|---|---|
| PSA recurrence | — |
Countries
Japan
Contacts
Public ContactSachika Shiraishi
Shonan kamakura general hospital Radiation Oncology
Outcome results
None listed